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Abstract
Sepsis is one of the leading causes of death in Intensive Care Units (ICU). The strategy for treating
sepsis involves the infusion of intravenous (IV) fluids and administration of antibiotics. Determining the
optimal quantity of IV fluids is a challenging problem due to the complexity of a patient’s physiology.
In this study, we develop a data-driven optimization solution that derives the optimal quantity of IV
fluids for individual patients. The proposed method minimizes the probability of severe outcomes by
controlling the prescribed quantity of IV fluids and utilizes human-in-the-loop artificial intelligence. We
demonstrate the performance of our model on 1122 ICU patients with sepsis diagnosis extracted from
the MIMIC-III dataset. The results show that, on average, our model can reduce mortality by 22%. This
study has the potential to help physicians synthesize optimal, patient-specific treatment strategies.
KEYWORDS: Sepsis; Fluid resuscitation; Artificial intelligence; Optimization; Inverse classifier
1 Introduction
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Each
year, at least 1.7 million adults develop sepsis [1]. Patients with sepsis are at considerable risk for severe
complications and death; one in three hospital deaths are due to sepsis [1]. The cornerstone of sepsis
treatment is antibiotic administration and fluid resuscitation to correct hypotension. Studies have shown that
the type of fluid resuscitation is correlated with mortality [2], and prescribing excess quantity of intravenous
(IV) fluids to septic patients could be detrimental [3]. Because of the significance of IV fluid in managing
sepsis patients, it is critical to understand what type of fluid and what amount of fluid should be administered.
∗Akash Gupta and Michael T. Lash equally contributed to this study.
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In this study, we develop a prescriptive clinical model that deduces optimal, patient-specific IV fluid values
for the treatment of sepsis.
The international community, Survival Sepsis Campaign (SSC), recommends early goal-directed therapy
(EGDT) that underlines the importance of rapid volume resuscitation [4]. Among septic patients, IV therapy
is employed as a volume expander in the event of blood loss to keep the body tissue oxygenated. There are
two types of volume expanders: Crystalloids and Colloids. Since colloids do not show clear benefits over
crystalloids in treating critically ill patients despite their higher cost [5], we aim at finding the right type of
crystalloids. The types of crystalloids considered in this study are: Dextrose (a synonym for glucose) 10%
in water (D10W), Dextrose 5% (D5W), Dextrose 5% in Normal Saline (D5NS), 5% Dextrose in half normal
saline (D5HNS), Dextrose 5% in Lactate Ringer (D5LR), Normal Saline (NS), Half Normal Saline (HNS),
and Lactated Ringer (LR). Due to the complexity of patient physiology, there is no consensus on treatment
strategy. The lack of treatment standards further complicates the treatment process for inexperienced junior
doctors.
In hospitals, junior doctors are usually responsible for initiating the immediate treatment of patients with
severe sepsis for two reasons. First, on-call systems in hospitals are designed to first contact junior doctors
when the condition of the patient deteriorates (often governed by the triggering of an early warning system).
Second, junior doctors are often the first to attend to patients following hospitalization. SSC guidelines
recommend varying the amount of fluid infusion at different disease severity levels. The study showed that
20% of all adults receiving fluid resuscitation experience complications owing to inadequate quantity of fluid
resuscitation [6]. By the time senior doctors review the treatment, the early intervention window has passed,
which is critical for sepsis treatment [7]. Therefore, developing a clinical tool that can help junior doctors
to deduce an optimal treatment is critical.
Some of the significant barriers to clinical models being accepted in the medical community are the issues
of interpretability and explainability: medical practitioners expect a model to be transparent and should
provide meaningful recommendations. Part of the novelty of our proposed method is that the model considers
the physician’s own treatment recommendation when eliciting an optimized recommendation. Furthermore,
the model can be parameterized to only deviate a small amount from the physician-provided values. Thus, our
physician in the loop formulation ensures that medical practitioners can trust the provided recommendations.
The method is designed to provide recommendations that are tailored to each patient’s physiology.
Patient physiology is characterised using clinical data available in Electronic Health Records (EHR). EHR
data is collected throughout a patient’s hospital stay. Figure 1 illustrates a patient’s flow through a hospital
system, and also highlights the contribution of this paper. Various clinical signs can be collected as the patient
progresses through the hospital system. A patient with a suspected infection enters the hospital where the
primary assessment of disease criticality is performed. Depending on the severity of the disease, a patient
may be recommended for hospitalization. Alternatively, a patient who has been hospitalized may develop
signs of infection during the inpatient stay. Following the SSC guidelines, the physician can recommend a
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specific amount of IV fluids. Our model combines the physician recommendation and the patient’s clinical
and demographic measurements to determine the optimal quantity of the IV fluids that improves survival
probability.
Figure 1: Patient flow in hospital
This study makes the following contributions:
1. Formulates a generalized optimization model to prescribe the optimal, patient-specific treatment.
2. Develops a tool to derive the optimal quantity of IV fluids for septic patients in ICUs.
3. Underlines the performance differences between the presence and the absence of human interactions in
decision making using the proposed prescriptive model.
4. Proposes a feature selection procedure that integrates well with the established modeling framework.
5. Augments the theoretical literature on inverse classifiers.
Our devised human in the loop method is based on an inverse classification framework [8, 9]. This
framework includes two steps. First, some arbitrary classifier is trained that best predicts mortality. We
employ logistic regression and deep learning classifiers in our experiments. Second, the selected model is
embedded into an optimization formulation that takes patient data and physician-provided fluid resuscitation
recommendations as input to derive the optimal IV fluid recommendations.
The rest of this paper is structured as follows. Section 2 reviews relevant literature, including existing IV
fluid-based sepsis treatment recommendation models and applications of inverse classification to healthcare
problems. Section 3 describes the proposed method in detail. Section 4 introduces the EHR data utilized in
our experiments to evaluate our methodology. Section 5 presents the experimental settings and numerical
results. Finally, Section 6 summarizes the contribution of this study.
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2 Literature Review
Due to complex pathophysiology, the treatment of sepsis imposes many challenges. As a result, the World
Health Organization passed a resolution to improve the definition, diagnosis, and treatment of sepsis [10]. The
SSC, in their guidelines, advocate for initial fluid resuscitation to treat sepsis effectively [11]. They specified
that within three hours of sepsis detection, the patient should be prescribed 30 mL/kg of IV crystalloid
fluid. However, the prescribed quantity should also be administered considering the patients’ mass and
other important vital signs [12]. Due to the threat sepsis imposes to human life, many studies have shown
that the fluid amount should be considered critically rather than reflexively. Chang and Holcomb (2016)
study different fluid resuscitation options available for treating sepsis patients [13]. The study discusses the
basic physiology, science of intravenous fluid, and compares balance and unbalanced crystalloids. Durairaj
and Schmidt (2008) indicated in their review paper that excessive fluid resuscitation can lead to adverse
outcomes [14]. The authors recommended the use of a dynamic index to determine the fluid amount.
This recommendation could be achieved by utilizing optimization models to prescribe patient-specific fluid
amounts.
Some researchers have applied machine learning techniques to determine optimal sepsis treatment strate-
gies. Komorowski et al. (2018) proposed a model to derive an optimal treatment strategy for sepsis using
reinforcement learning [15]. The proposed model harvests the optimal treatment by comparing many treat-
ment decisions. Raghu et al. (2017) extended (pre-print version) the work from [15] by employing the
continuous state space solution approach to derive optimal sepsis treatment strategy [16]. The authors
optimize the quantity of IV fluids and vasopressors such that the treatment outcome can be improved.
An optimization-driven tool could support junior doctors in determining optimal IV fluid treatments,
who are usually among the first to treat patients. Courtney et al. (2014) studied the infusion of intravenous
fluids to patients by junior doctors. The study found that the majority of junior doctors do not prescribe
the right amount of fluid and fail to adjust for volume by mass [6]. The results of this study highlight the
importance of a convenient, human (physician) in the loop method that can aid junior physicians in making
the right IV fluid prescription.
A few studies have shown that early fluid resuscitation is associated with reduced mortality. Lee et al.
(2014) studied the correlation between aggressive, optimal fluid resuscitation administered during the early
stages of treatment [17]. The study found that earlier fluid resuscitation administered in adequate quantities
is associated with decreased mortality. Cohen et al. (2015) suggested that, in the absence of any specific
anti-sepsis treatment, the early administration of antibiotics and optimal infusion of fluid resuscitation is
critical. This study designs a framework that can alert physicians to the risk of mortality during the early
stages of a septic episode and assists physicians in prescribing an optimal treatment strategy using our
devised inverse classification framework.
Recommender systems attempt to find the items, services, products, etc. that will lead an individual to
be most satisfied. Such methods are typically implemented in environments that contain an over-abundance
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of decisions, thereby leading users of the environment to a state of “information overload”. For instance,
the popular movie and TV streaming website Netflix employs a recommender system to filter through the
thousands of entertainment options and display those that the customer will most enjoy. Notions of “most
satisified”, “most enjoyed”, etc. are expressed in terms of some numerical measure. On Netflix, for instance,
users express whether or not they enjoyed a particular TV show or movie by “liking” or “disliking” it. The
recommender systems leverage a user’s past “likes” and “dislikes” to recommend not-yet-watched movies
and TV shows that align with the user’s preferences. Broadly speaking, recommender systems literature
can be decomposed into three categories: collaborative filtering methods [18], which make recommendations
based on user information, content-based filtering methods [19], which make recommendations based on
content information, and hybrid filtering methods [20], which make recommendations based on both user
and content information.
In more recent years, recommender systems methodology has been incorporated into a deep learning
paradigm. Deep learning methods can be either collaborative, content-based, or hybrid-based depending
on the type of information used as input. These methods are best decomposed in terms of the type of
neural network architecture employed. Deep recommender systems employing convolutions [21], recurrent
units [22], “vanilla” MLPs [23], and auto-encoders [24] have all been explored, as have graph-based methods
[25, 24].
While recommender system methodology is important work to consider provided our problem setting,
it is not best suited to such a setting since an over-abundance of decisions is not the issue. A related
recommendation technology is referred to as inverse classification. Inverse classification makes use of an
induced classification model to find the feature value perturbations that optimize for a particular outcome of
interest (measured by the induced classifier); the feature value perturbations represent the recommendations.
For instance, a model might be induced to learn the mapping from patient characteristics, such as age, blood
pressure, and fluid amounts, to a disease outcome of interest, such as survive/die from sepsis (as we do in
this paper). Inverse classification will then use this model to find the perturbations to a new patient’s feature
values (i.e., IV fluids prescribed by the physician) that optimally minimize the probability of death due to
sepsis.
Inverse classification has previously been applied to a variety of domains, including cardiovascular disease
risk mitigation [26, 27, 8, 9, 28], hiring in nurseries [29], bankruptcy prediction and alleviation [30], diabetes
[31], and student classroom performance [8, 9, 28]. Several select works use inverse classification to explain
rather than prescribe [31, 32]. Methodologically speaking, past inverse classification works can be stratified
by those employ constraints [31, 26, 8, 9, 33, 27] and those that do not [29, 30]. Constraints encourage
solutions that are real-world feasible and personable (i.e., can be tailored to each individual’s preferences)
and are therefore desirable. Furthermore, some inverse classification methods are model-specific [29, 31, 26,
33, 30, 27], relying on the use of a specific predictive model, while others are model agnostic [8, 9, 28]. If
a particular model is able to accurately map the probability space of a particular problem, then a model-
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specific inverse classification method may be most appropriate. The best/most accurate model is rarely
known apriori and is therefore why model-agnostic inverse classification methods are generally preferred.
Several studies have shown that human interactions combined with machine learning methods can posi-
tively influence decision making [34]. Holzinger et al. (2016) performed numerical experiments to show the
advantages of human interactions in solving optimization problems and concluded that human-in-the-loop
can significantly improve the solution and the computation time [35]. Duhaime (2016) advocates integrating
humans and artificial intelligence to solve healthcare problems [36]. The author claims that such models are
more reliable and trustworthy due to the blend of physicians’ knowledge and artificial intelligence.
3 Proposed Methodology
In this section we disclose our proposed human in the loop method of eliciting optimal, patient-specific
fluid resuscitation amounts to reduce the probability of death due to sepsis. The proposed prescriptive
model first determines the best predictive model to estimate mortality probability. The selected model
is then embedded in an optimization formulation to derive the optimal amount of IV fluid. We describe
the selection of predictive model in Section 3.1 and the optimization formulation in Section 3.2. Prior to
disclosing our framework we first provide some relevant preliminary notation.
Let {x(i), y(i)}ni=1 denote a dataset of n instances (patient visits), where x ∈ X ⊂ Rp and y ∈ {0, 1}. A
value of y = 1 indicates that a patient has died of sepsis and y = 0 indicates that a patient has survived. p
is the size of feature vector x, which represents the number of clinical variables. These include demographic
measurements, such as age, vitals, such as blood pressure, lab-based measurements, such as serum creatinine,
and the physician-prescribed treatment measurements. However, only specific feature categories can actually
be manipulated to affect (i.e., change) the final outcome (survive or not). For instance, one cannot change
his or her age, but we can change the amounts of the various IV fluids administered to the patient to
improve their probability of survival. Additionally, while certain measurement categories cannot be directly
manipulated, the values of the features in these categories may depend and vary according to feature values
in other categories. For instance, blood pressure may be a function of both age and the administration of
certain drugs.
We first ascribe notation to these different categories. Let U denote the indices in x that correspond to
unchangeable features, such as demographic information, D denote the indices corresponding to the directly
changeable features, such as IV fluids, and I denote indirectly changeable features, such as vitals and lab-
based measurements. Using these index sets the feature vector x can be decomposed into xU ,xI ,xD to refer
to specific feature values – i.e., x = (xU ,xI ,xD). The feature sets of xU ,xI and xD are denoted using FU ,
FI and FD, respectively; these notations are used predominantly in Section 4.3 to explain feature selection.
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3.1 Predicting Sepsis Outcomes
With the above preliminaries explained, an initial model that provides probabilistic estimates of sepsis
outcomes is formulated as follows:
yˆ = f(xU ,xI ,xD) =
1
1 + e−g(xU ,xI ,xD)
, (1)
where f(·) is the logistic sigmoid function applied to another function g(·) that takes x as input. Such a
formulation allows for flexibility in defining the model used to make predictions, while still ensuring that
probabilistic outputs are obtained from the model. A model that outputs probabilities is important since
we wish to minimize the probability of a negative outcome directly, rather than minimizing over a set of
discrete outcomes such as {alive,not alive}. When a logistic regression model is used, the g(·) function can
be expressed as a linear combination of learned parameters and an instance feature vector:
glogistic(x) = [b,θ]
>
[1,x] = b+
p∑
j=1
θjxj , (2)
where b and θ are the learned parameters. If g(·) is a more complex model, albeit still of the variety that
can be trained to learn a probability mapping, like a neural network, the function can be expressed as:
gNN(x) = w
>
k hk−1
(
Wk−1 . . . h1 (W1x)
)
, (3)
where wk is a parameter vector for the kth (i.e., output) layer, Wj : j = 1, . . . , k− 1 are parameter matrices
associated with the k−1 hidden layers, and hj : j = 1, . . . , k−1 are each some arbitrary, non-linear activation
function (e.g., Rectified Linear Unit (ReLU), sigmoid, etc.). An activation function is a general non-linear
mathematical function that transforms input in a way that is meant to mimic the firing of a neuron. The
ReLu activation function, for instance, is defined as:
hk(Wkx) = max(0,Wkx)
When either glogistic or gNN are selected for use with f , then f and g are learned jointly through a gradient
descent optimization process – e.g., gradient descent, projected gradient descent, stochastic gradient descent
(in the case of gNN), etc. If the selected learning algorithm does not natively provide probability estimates,
however (e.g., g is an SVM model), then g must be learned separately from f , and f reduces to a specific
application of Platt Scaling [37].
Defining f and g, as generally as we have, allows us to define a considerably larger hypothesis space H
to search across when attempting to find the optimal model to use in our inverse classification framework.
The model selection process can be briefly expressed as follows:
f∗ = argmax
f∈H
{
Evaluate
(
f,Xval, c
)}
(4)
where the validation set Xval = {x(i)val}nvali=1 is evaluated on trained classifier, f , based on the classification
measures, c. In our experiments, classification performance is measured using accuracy and the Area Under
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the Receiver Characteristic Curve (AUC), explained in Section 5.2. The increased search size of H is of
significance since the quality of our life-saving recommendations are directly tied to the quality of the model
and accuracy of the probability space mapping.
3.2 Inverse Classification for Optimal Dose Prescriptions
Using the general model defined in Equation (1) we can obtain probabilistic estimates of death due to sepsis
yˆ for some instance x. This model will form the basis for our method of eliciting optimal, patient-specific
fluid resuscitation recommendations, which we discuss in this subsection.
Our recommendation formulation is based on inverse classification, which is the process of manipulating
the feature values of an instance in order to minimize the probability of an undesirable outcome. In this
case, the instances are “sepsis patients” and the undesirable outcome is “death”. Therefore, our formulation
will minimize the probability of death, which can be expressed:
min
x˜
f (x˜) (5)
where x˜ is a test instance whose feature values are freely manipulable by the optimization process.
The initial formulation, Equation (5), does not include real-world feasibility considerations, however. For
instance, it would make little sense to allow the formulation to manipulate the xU feature values, such as
age. Moreover, the extent of changes allowed by Equation (5) is unbounded and may produce nonsensical
recommendations, such as negative fluid amounts, as a result. Finally, Equation (5) doesn’t take into account
variable dependencies and interactions. As an example, blood pressure, an indirectly changeable feature, is a
function of the unchangeable features xU , such as age, and the directly changeable features xD, representing
IV fluids. Since we are manipulating the xD (i.e. IV fluids), we can expect blood pressure to also change as
a result, and because one’s blood pressure has an impact on whether one lives or dies, it is critical to capture
these dependencies during optimization
To account for the dependencies that exist between xU ,xD and xI , as discussed in the preceding para-
graph, we propose to use a so-called indirect feature estimator (IFE). Let H : XU,D → X I denote a function
that takes the U and D features as input and provides estimates for the I features, i.e.,
xˆI = H (xU ,xD) . (6)
Using H(·), we can account for how changes to the xD features affect the xI features. The IFE can be any
differentiable regression model and is therefore also fairly flexible. To be more concrete, we explicitly require
a differentiable model because our optimization methodology relies on gradient information. In this study,
we employ linear regression and neural networks. If we need to relax the assumption of differentiablility then
the optimization methodology would need to be adjusted accordingly (e.g., heuristic optimization). Relaxing
this assupmtion may broaden the IFE hypothesis space at the cost of optimality guarantees.
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Considering that 1) the xI feature values are governed by xU and xD and 2) only the xD feature values
can be manipulated, the naive inverse classification formulation of (5) can be transformed into:
min
x˜D
f
(
xU , H (xU , x˜D) , x˜D
)
, (7)
where x˜D are now the decision variables (to reflect the fact that only these variables should be changed).
While Equation (7) is an improvement over Equation (5), there are still necessary considerations missing
from the formulation. Namely, Equation (7) is unconstrained, which may allow the formulation to produce
nonsensical recommendations, such as negative fluid resuscitation amounts. Additionally, since a key com-
ponent of our method is human in the loop functionality (i.e., “doctor in the loop” functionality), we wish
to restrict the extent of the manipulations made to the expert-specified xD feature values. To be a bit more
explicit, our rationale is that a doctor’s prescribed fluid resuscitation amounts reflect a coarse-grained recom-
mendation. Our inverse classification method will then refine this initial, doctor-specified recommendation
to provide a fine-grained, precise recommendation that does not deviate “too far” from that specified by the
doctor.
Therefore, we update Equation (7) by adding feasibility constraints to prevent nonsensical recommenda-
tions as follows:
min
x˜D
f
(
xU , H (xU , x˜D) , x˜D
)
(8)
s.t. ‖z‖1 ≤ b
0 ≤ x˜D ≤ 1
where z = x˜D − xD and b is a budget term that controls the extent of recommendations allowed. Note that
x˜D are the updated feature values and xD are the physician-provided feature values.
The b constraint is best calibrated to each physician user in an offline setting, prior to deployment. If a
physician is more experienced, the b term can likely be smaller than if the physician is less experienced. A
smaller b term will produce smaller recommendations since the cumulative change recommended is restricted.
The last line of Equation (8) specifies that recommendations must be non-negative, but also less than or
equal to one. This latter consideration is based on the assumption that all features have been normalized to a
zero-one range and allows us to further encourage the process to produce real-world feasible recommendations.
Figure 2 illustrates the inverse classification formulation in terms of the feature value categories. Note that
the human in the loop (HITL) treatments denote the physician-provided IV fluid values.
The final formulation, Equation (8), can be optimized using project gradient descent (PGD), which is an
efficient gradient-based optimization method [38]. Therefore, the updates to the x˜D feature values at each
9
Demographic, etc. HITL treatment
Optimized treatment
Figure 2: A depiction of our human in the loop formulation. HITL: human in the loop
iteration t = 1, . . . , T of PGD can be expressed by:
x˜
(t+1)
D = Π∆
(
x˜
(t)
D − η(t)
∂f
x˜
(t)
D
)
(9)
= Π∆
x˜(t)D − η(t)
[
∂f
∂x˜
(t)
D
+
∂f
x˜
(t)
I
∂H
x˜
(t)
D
]
= Π∆
(
x˜
(t)
D − η(t)∇f
)
where Π∆ (·) is the projection operator that projects the input onto the feasible region ∆, x˜(t)I = H
(
xU , x˜
(t)
D
)
,
and η is a learning rate. Note that the gradient depends in part upon the estimate of the xI feature values.
Further note that the projection done by Π (·) onto the feasible region ∆, dictated by the constraints in (9),
can be achieved efficiently and always succeed (as long as the feasible region ∆ 6= ∅) [9].
4 Data Preparation
4.1 Data
This study extracted EHR data from MIMIC III (Medical Information Mart for Intensive Care III) [39]
to demonstrate the performance of the proposed methodology. These clinical data are freely-available de-
identified electronics health records consisting of over sixty thousand patients (61,532) hospitalized in critical
care units (ICU) at the Beth Israel Deaconess Medical Center between 2001 and 2012. We selected the adult
patient visits with a diagnosis of sepsis for use in our study.
4.2 Data pre-processing
Several necessary pre-processing steps were taken to curate our final dataset. Figure 3 illustrates these data
preparation steps. The data, initially available in multiple tables, are merged to consolidate information
about patients, clinical observations and treatments. A particular challenge when pre-processing medical
data is the plethora of terms conveying the same meaning (synonyms), which must be accounted for when
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deriving a suitable dataset for this study. For example, respiratory rate is recorded as Respiratory Rate,
Breath rate, Res. rate etc..
Ultimately, the derivation of the dataset used in our study is performed using a clinical expert’s opinions
and by consulting the relevant literature [15, 40]. For each patient visit, the clinical variables are recorded
longitudinally (i.e., are measured across time). We then aggregate the longitudinal data by computing the
mean of each clinical variable for each visit. This aggregation approach was also performed for IV fluids.
Any missing data is imputed using multiple imputation by using the chain equation approach [41].
Figure 3: Data preparation steps
Pre-processing the data results in a total of 1122 patient visits with a diagnosis of sepsis. We extracted
information about 30 features for these patient visits. The statistical summary (minimum, first quarter,
second quarter or median, mean, third quarter and maximum) of each feature is included in Table 1. The
mean and the median age of patients is 68 and 79 years, respectively. Among all patient visits, the outcome
for 244 (22%) visits is expired. The data include a large proportion of patient visits with severe outcome
because the study focuses on ICU patients.
Besides demographics, vitals, and lab-based data, we also extracted the physician-prescribed dosage of
IV fluids. Table 2 lists the names of IV fluids, as recorded in the dataset. As mentioned earlier, a key
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Table 1: Statistical summary of clinical features (Q1: first quarter, Q2: second quarter, Q3: third quarter)
Clinical Variables (units) Minimum Q1 Median or Q2 Mean Q3 Maximum
Base Excess (mEq/L) -31.0 -5.0 -2.3 -2.7 0.0 16.5
Blood CO2 (mEq/L) 4.5 19.8 22.6 22.8 25.8 44.0
Blood Hemoglobin (g/dL) 6.0 9.1 9.9 10.1 11.0 19.5
Blood Urea Nitrogen (mg/dL) 1.0 17.0 29 36.01 48.2 212.5
Body Temperature (◦F) 47.4 97.5 98.1 98.1 98.8 107.2
Diastolic Blood Pressure (mmHg) 18.0 50.8 56.4 57.1 63.0 90.3
Glasgow Coma Scale Score 3.0 10.6 13.9 12.5 15.0 15.0
Heart Rate (/min) 46.6 78.4 88.2 89.0 98.9 137.3
Hematocrit (%) 19.7 27.8 29.9 30.7 32.9 61.6
Lactate (mg/dL) 0.6 1.5 2.0 2.5 2.9 18.3
O2 Flow (L/min) 0.3 2.2 3.4 5.1 6.3 100.0
PaCO2 (mmHg) 19.0 33.6 38.5 39.8 43.8 121.0
PaO2 (mmHg) 27.0 83.0 104.1 108.1 127.5 350.0
pH 2.4 7.3 7.4 7.4 7.4 53.5
PO2 (mmHg) 26.0 73.3 100.0 103.9 126.7 467.0
PT (s) 11.6 13.8 14.9 16.6 17.6 55.2
PTT (s) 14.9 24.0 27.9 31.7 35.4 128.3
Platelet count (x1000/mm3) 16.8 145.7 215.3 227.5 288.0 985.0
Respiratory Rate (/min) 10.7 17.7 20.3 20.5 22.9 38.1
Serum Creatinine (mg/dL) 0.2 0.8 1.2 1.9 2.0 141.9
Serum Chloride (mEq/L) 84.0 102.6 106.2 106.1 109.6 137.6
Serum Glucose (mg/dL) 30.3 107.9 126.7 135.4 150.8 447.7
Serum Magnesium (mEq/L) 1.1 1.8 2.0 2.0 2.1 18.3
Serum Potassium (mEq/L) 2.7 3.7 4.0 4.1 4.3 7.3
Serum Sodium (mEq/L) 118.3 136.9 139.2 139.3 141.8 163.1
Systolic Blood Pressure (mmHg) 0.0 102.2 109.9 111.7 120.7 210.1
WBC Count (x1000/mm3) 0.5 8.3 11.7 13.2 15.8 97.1
Age (years) 19.0 56.3 68.0 66.4 79.0 89.0
Median Weight (kg) 0.0 63.8 76.8 80.3 90.8 233.9
medical data challenge is the use of synonymous terms; many IV fluids are recorded with different names,
but refer to the same fluid. We translate these synonymous fluid names into a standard convention following
a clinical expert’s suggestions. This study incorporates nine different types of IV fluids. Additives/solutes
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(e.g. potassium chloride) that were administered via an IV infusion were parsed to obtain the type of the
underlying IV fluid. We assume that the absence of a specific type of IV fluid for a patient indicates that
the specific type of IV fluid was not prescribed.
Table 2: Available types of IV fluids in the dataset
IV name (in dataset) Standardized IV fluid name Standardized acronym
D10W Dextrose 10% in Water D10W
D5 1/2NS D5 1/2NS D5HNS
Potassium Chl 20 mEq / 1000 mL D5 1/2 NS D5 1/2NS D5HNS
Potassium Chl 40 mEq / 1000 mL D5 1/2 NS D5 1/2NS D5HNS
D5LR Dextrose 5% in Lactated Ringer D5LR
D5NS Dextrose 5% in Normal Saline D5NS
Iso-Osmotic Dextrose Dextrose 5% D5W
D5W Dextrose 5% D5W
5% Dextrose Dextrose 5% D5W
Dextrose 5% Dextrose 5% D5W
D5W (EXCEL BAG) Dextrose 5% D5W
5% Dextrose (EXCEL BAG) Dextrose 5% D5W
Potassium Chl 40 mEq / 1000 mL D5W Dextrose 5% D5W
Amino Acids 4.25% W/ Dextrose 5% DNS
1/2 NS Half normal saline HNS
0.45% Sodium Chloride Half normal saline HNS
LR Lactated Ringers LR
Lactated Ringers Lactated Ringers LR
NS Normal Saline NS
SW Normal Saline NS
0.9% Sodium Chloride Normal Saline NS
0.9% Sodium Chloride (Mini Bag Plus) Normal Saline NS
NS (Mini Bag Plus) Normal Saline NS
Iso-Osmotic Sodium Chloride Normal Saline NS
Isotonic Sodium Chloride Normal saline NS
NS (Glass Bottle) Normal Saline NS
Potassium Chl 40 mEq / 1000 mL NS Normal Saline NS
Potassium Chl 20 mEq / 1000 mL NS Normal Saline NS
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4.3 Feature Selection
Oftentimes a model with superior predictive performance can be produced by including/excluding certain
features. The process of discovering the group of features that produces this superior model is called feature
selection. Because the inverse classification procedure relies on an underlying model to make life-saving fluid
resuscitation recommendations, it is of paramount importance that the most accurate model be learned.
Therefore, we propose to employ feature selection methodology to further improve model performance and
thereby the accuracy of the probability space mapping captured by the learned model. Therefore, we propose
a Classifier Subset Evaluation-based (CSE) feature selection method, disclosed by Algorithm 1. Our CSE
method can be viewed as a specific implementation of the more general ClassifierSubsetEval method found
in Weka [42].
Algorithm 1 takes as input a training set {x(i), y(i)}ni=1, the full feature set F , an arbitrary classifier
fθ with any necessary, user-specified parameters θ, a classifier performance measure c, such as accuracy or
AUC, and s, which specifies the number of consecutive non-improving iterations allowed before termination.
Upon execution, the algorithm initializes Fopt, which will hold the selected features, to an empty set, k,
which counts the number of iterations, is initialized to zero, the termination criteria term is initialized to
false, c(k) is the performance of the classifier trained at the kth iteration with c(0) initialized to 0, δ, which
measures classifier improvement in terms of c by adding the feature at the kth iteration (i.e., c(k) − c(k−1)),
is initialized to infinity,and s′, which represents the number of successive, non-improving iterations currently
observed, is set to 0. From here the algorithm begins iterating until term is set equal to true, the conditions
for which are expressed on lines 14 and 15 and will be explained momentarily.
At each iteration, k is incremented by one, a feature f ∼ U (F) is randomly selected from F , and F is
updated to exclude the selected feature (F ← F \ f) (line 3). Next (line 4), the selected feature is added
to Fopt where, subsequently, a model fθ is trained using only the Fopt features (line 5) and evaluated in
terms of metric c to obtain c(i); δ is then computed on line 6. On line 7, δ is evaluated to see if adding f
has improved predictive performance (this occurs when δ > 0). If f does not improve the model (δ = 0), or
worsens model performance (δ < 0), then the addition of f to Fopt is undone: f is re-added to F (lines 8-9),
and s′ is incremented (line 10); otherwise (i.e., δ > 0) s′ is set to zero (lines 11-12). Line 14 specifies the
termination criteria: if s concurrent iterations have failed to produce an improvement or if all features have
been added to Fopt. Utilizing the outlined CSE-based feature selection method, we improve the predictive
performance of our model and thereby the accuracy of the probability space mapping.
5 Results
Previously, we elaborated on our proposed methodology and the selected clinical dataset. In this section we
illustrate the performance of our model on this clinical dataset. The experimental results are stratified into
five segments. First, we experiment with our CFS-based feature selection method while searching for the best
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Algorithm 1 Classifier Subset Evaluation ClassSubEval
(
{x(i), y(i)}ni=1,F , fθ , c, s
)
Require: {x(i), y(i)}ni=1, F , fθ , c, s
1: Initialize Fopt ← {}, k ← 0, δ ←∞, term← False, c(0) ← 0, s′ ← 0
2: while term == False do
3: k ← k + 1, f ∼ U (F), F ← F \ f
4: Fopt ← Fopt ∪ f
5: c(i) ← trainc
(
{x(i), y(i)}ni=1, fθ ,Fopt
)
6: δ ← c(i) − c(i−1)
7: if δ ≤ 0 and |Fopt| 6= 1 then
8: Fopt ← Fopt \ f
9: F ← F ∪ f
10: s′ ← s′ + 1
11: else
12: s′ ← 0
13: end if
14: if s′ == s or F == ∅ then
15: term← True
16: end if
17: end while
Ensure: Fopt
15
predictive model. The best model and the selected subset of features are used in subsequent experiments.
Second, we conduct experiments to find the best IFE. Third, using our optimal predictive model and optimal
IFE, we derive optimized treatments relative to budget constraint b. Fourth, we perform a robustness check
of our model to evaluate performance should physician recommendations not be available. Finally, we present
the average changes recommended by our method relative to several selected budget constraint values b.
All results were obtained by first randomly partitioning our dataset into training, validation, and test
sets. Since only approximately 20% of the dataset instances (patient visits) belong to the positive class, we
ensured that equal proportions of positive instances were allocated to each set (i.e., 20% of the instances
in each training, validation, testing set are positive). Dataset sizes were selected to be 80%, 10%, and 10%
for training, validation, and test sets, respectively. All f and H models were trained using the training set.
The best type of each model (f∗, H∗) was selected based on validation set performance. The testing set
was reserved for evaluating our recommendations and was not used in constructing or selecting predictive
models. Finally, all features are normalized to a range of [0, 1] using min-max scaling.
5.1 Variable Selection
As discussed in Section 3.1, we need to search across H and select the best predictive model (f∗) to estimate
the probability of mortality (Equation 4). Our first model-building step is to eliminate clinical features
that do not contribute to the prediction, and may even detract from predictive performance. Therefore,
we establish a variable selection procedure (outlined in a preceding section) that integrates well with our
problem setting (and is one of the contributions of this paper).
Table 3 lists both independent (or predictors) and dependent (or response) features. The independent
variables are divided into three categories: xD, xI and xU . In our dataset, the amount and the type of the
prescribed IV fluid are under direct control of the physician; hence, such variables are in the category of
directly changeable features (xD). The vitals (e.g., heart rate, blood pressure) and lab-based measurements
(e.g., creatinine, white blood cell count) can not be manipulated directly, but can be manipulated indirectly
through manipulation to the administered IV fluids (the xD features). Therefore, all patient vitals and
lab-based measurements fall under the category of indirectly changeable features (xI). The dataset also
includes variables such as age, gender etc. These patient attributes can not be altered. Hence, demographic
features fall under the category of unchangeable features (xU ).
Feature selection was performed using CSE, discussed in Section 4.3. CSE can be applied to each f ∈ H
in an “online” fashion, or as a pre-processing step, where a single f is selected and used to find the subset of
features that will be used when searching for f∗ ∈ H. We adopt the latter, pre-processing strategy to reduce
experiment compute time. Our selected f was a neural network model trained for 150 epochs with a single
hidden layer containing three hidden nodes. This particular parameterization of f was selected because it
is representative of the parameterizations explored during the model tuning phase, the results of which are
discussed in the next subsection.
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Table 3 shows the variables before and after employing the variable selection procedure. The variable
selection results show that D5HNS, D5LR, D5W, LR and NS are the only fluids that affect the probability
of mortality significantly. We also observe that the size of the indirect variable set has been reduced from
27 to 20 features. Discharge type is considered the outcome, or dependent feature. In the next subsection,
we show the performance of the predictive model on the data with the complete set and on the data with
the selected features.
Table 3: Clinical features in the dataset
Variable category Notation Complete set of variables Selected variables
Independent xD Amount of fluid resuscitation
(D10W, D5HNS, D5LR, D5NS,
D5W, DNS, HNS, LR and NS)
D5HNS, D5LR, D5W, LR, NS
xI Base excess, blood CO2, blood
hemoglobin, blood urea nitrogen,
body temperature, diastolic blood
pressure, Glasgow Coma Scale,
heart rate, hematocrit, lactate, O2
flow, PaCO2, PaO2, pH, PO2, PT,
PTT, platelet, respiratory rate,
serum creatinine, serum chloride,
serum glucose, serum magnesium,
serum potassium, serum sodium,
systolic blood pressure, WBC (27
variables)
Base excess, blood CO2, blood
hemoglobin, blood urea nitrogen,
diastolic blood pressure, Glasgow
Coma Scale, heart rate, hemat-
ocrit, lactate, PaCO2, PaO2, PO2,
PTT, platelet, respiratory rate,
serum creatinine, serum glucose,
serum sodium, systolic blood pres-
sure, WBC (20 variables)
xU Age, gender, weight Age, gender
Dependent y Discharge type (binary) Discharge type
5.2 Predictive Model Tuning
In Section 5.1, CFS is utilized to find the best subset of features. In this section, we employ a grid search
to find the model f∗ that has the best predictive performance and therefore the best probability space
mapping. We apply the grid search to two datasets: a dataset containing the full set of features and a
dataset containing only those features that were selected using CFS. This will allow us to choose not only
the best model, but to assess whether CFS is in fact able to produce a superior model. We limit our study
to logistic regression (glogistic(x)) and neural network variants (gNN(x)). After determining the optimal f
∗
and dataset, a grid search is performed to find the optimal IFE function H∗. We limit this grid search to
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multivariate linear regression and variants of neural networks.
Accuracy and AUC are employed to assess the performance of our classification models f ∈ H. Accuracy
is defined as the ratio obtained by dividing the number of correctly predicted instances by the total number
of instances. As a metric, however, accuracy is susceptible to class imbalance, which is present in our dataset
(i.e., only 20% of instances are positive). Therefore, we also adopt the AUC metric, which is insensitive to
class imbalance. AUC plots the true positive rate (TPR) against the false positive rate (FPR), thus creating
a curve. The area underneath this curve (called the receiver operating characterstic curve) is the AUC
(area under the curve). When a model predicts only the majority class (e.g., the model always predicts the
negative class), the AUC is 0.50 and is why AUC is considered insensitive to class imbalance. An AUC of
1.0 represents completely perfect predictions.
Table 4: Grid search results for both the original and “feature selection” datasets on a randomly held out
validation set. HN: Hidden nodes, Tr Acc: Accuracy on training data, Tr AUC: AUC on training dataset,
Val Acc: Accuracy on validation dataset, Val AUC: AUC on validation dataset
Models Parameters All Features Selected Features
HN Epochs Tr Acc Tr AUC Val Acc Val AUC Tr Acc Tr AUC Val Acc Val AUC
Logistic
100 0.8185 0.8988 0.7768 0.8523 0.8029 0.8820 0.7768 0.8257
150 0.8151 0.9001 0.7589 0.8510 0.8163 0.8953 0.7946 0.8437
200 0.8285 0.9101 0.7946 0.8695 0.8285 0.9058 0.8304 0.8615
250 0.8229 0.9111 0.7946 0.8665 0.8263 0.9101 0.8036 0.8654
NN
3 100 0.8296 0.9137 0.8036 0.8691 0.8263 0.9061 0.7857 0.8679
3 150 0.7996 0.8942 0.7589 0.8437 0.8096 0.8975 0.7679 0.8601
3 200 0.8408 0.9224 0.7857 0.8735 0.8318 0.9156 0.7946 0.8777
3 250 0.8374 0.9235 0.7768 0.8690 0.8374 0.9205 0.8125 0.8792
5 100 0.8285 0.9057 0.7857 0.8624 0.8007 0.8854 0.7679 0.8427
5 150 0.8151 0.8906 0.7679 0.8367 0.8051 0.8830 0.7768 0.8481
5 200 0.8452 0.9228 0.8036 0.8633 0.8352 0.9172 0.8214 0.8774
5 250 0.8530 0.9228 0.8036 0.8565 0.8352 0.9159 0.8125 0.8736
10 100 0.8218 0.9083 0.7857 0.8632 0.8196 0.8976 0.7679 0.8593
10 150 0.8140 0.8909 0.7768 0.8461 0.8040 0.8898 0.7768 0.8601
10 200 0.8463 0.9285 0.7946 0.8724 0.8474 0.9234 0.8125 0.8760
10 250 0.8419 0.9268 0.7768 0.8709 0.8441 0.9242 0.8125 0.8728
Table 4 presents the results of our grid search in terms of accuracy and AUC, obtained on both the
training and validation sets, on the two datasets (original and feature selected) discussed earlier in this
section. Note that “Tr” stands for “training set” and “Val” for “validation set”. We varied the number of
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training epochs from 100 to 250 for all models. We also varied the number of hidden nodes in our neural
network from 3 to 10. Note that logistic regression can be viewed as a neural network with no hidden nodes
and layers. The Adam optimizer was used for training all models with an initial learning rate set to 0.01
[43]. The best performing model f∗ is obtained using a neural network with three hidden nodes (AUC:
0.8792) on the “feature selection” dataset. Therefore we adopt this model and dataset for the remainder of
our experiments.
Next, we execute a grid search to find the optimal IFE function H∗. Recall that the IFE takes as input
xU and xD and provides estimates for xI and will be used during the recommendation procedure. Figure
4 illustrates the performance of the model in the validation dataset with 250 epochs. We explored epochs
ranging from 100 to 350 and found that 250 epochs produces the best results. Figures 4a and 4b show Mean
Absolute Error (MAE) and Mean Square Error (MSE), respectively. We utilized MSE as a performance
measure to select the best model. The results show that a neural network with ten hidden nodes produces
the best model with an MSE of 0.015.
(a) Mean absolute error (b) Mean square error
Figure 4: Model performance of indirect feature estimators on both the “original” and “feature selection”
datasets on a randomly held out validation set. NN-3, NN-5 and NN-10 are the neural network with 3, 5
and 10 hidden nodes, respectively
Table 5 lists the selected models that will be used in subsequent experiments.
Table 5: Selected modeling technique (star indicates the best selected model)
Functions Selected Model
f∗ Neural network with three hidden nodes and sigmoid output activation
H∗ Neural network with ten hidden nodes with no output activation
19
5.3 Human in the Loop Recommendations: Probability Improvement
Using the optimal f∗(·) and H∗(·), discovered in the preceding subsection, we apply our human in the loop
inverse classification formulation, discussed in Section 3.2, to the test set. The experiments are performed
by varying the budget b from 0.1 to 1 with an increment of 0.1. In these experiments the IV fluid values,
xD, specified by each physician are cumulatively allowed to be changed by only an amount b, according to
our formulation in Section 3.2. Therefore, larger values of b will allow larger changes to be made to the
physicians recommendation.
µ µ + 14σ µ -
1
4σ
(a) Average probabilities of mortality(along with quarter
of one standard deviation) vs. budget.
µ µ - 14σ µ +
1
4σ
(b) Average relative probabilities of mortality (along with
quarter of one standard deviation) vs. budget.
Figure 5: The average change in the probability of mortality over varying budgets.
Our method derives optimal, patient-specific IV fluid recommendations along with an estimated risk
(probability) of mortality (objective function) at the varying budget levels mentioned. Figure 5 shows the
average results across these different budget levels. Figure 5a shows the average (µ) probability of mortality
(i.e., death due to sepsis; y-axis) at each budget level (x-axis), as indicated by the blue line; the gray
shading indicates one quarter of one standard deviation above and below the average (µ± 14σ). As expected,
with increase in b, the probability of mortality is further reduced (on average). The average probability of
mortality with no adjustment in xD is 0.46, while the average probability of mortality with xD allowed to
be adjusted to the maximum (i.e., b = 1.0) is 0.37.
Figure 5b shows relative probability improvement (y-axis) at each budget setting (x-axis), indicated by
the the red line; the gray shading indicates one quarter of one standard deviation above and below the
average. With increase in b, the probability of mortality is further reduced (on average). We can observe
that the average relative improvement in mortality, provided limited budget b = 1.0, is about 22%, which
is significantly better than the 1.8-3.6% improvement devised by [16] . Therefore, the proposed model can
significantly improve the chances of survival by adjusting the infusion of IV fluids to the optimal value.
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5.4 Human in the Loop Recommendations: Robustness
In Section 5.3, we applied our proposed methodology to our dataset and showed the benefit in terms of
average probability improvement. The proposed model uses a physician’s recommendations to determine
optimal, patient-specific IV fluid dosing. However, we also wanted to investigate the robustness of our model
in the absence of any physician input. We refer to the scenarios where the physician’s recommendations are
incorporated as human-in-the-loop initialization, while the scenarios with no physician input are referred
to as random initialization. We are use the term initialization because the input xD values represent the
starting place for the optimization procedure. Therefore, the specified xD values likely have an impact on
the recommendation and, consequently, the amount of probability improvement that can be extended to
each patient (test instance). Therefore, we compare the results obtained using physician inputs to those
obtained using random inputs. For each test instance, we randomly initialized each of the xD features to
values in the range of [0, 0.1]. This range of values was selected to reflect a cautious initialization (i.e., small,
rather than large values).
Figure 6 illustrates the results obtained using human-in-the-loop initialization and random initialization.
Similar to the results presented in the preceding subsection, we show both actual and relative probability
improvement at varying budget levels. Figure 6a show the average probability improvement results. The
x-axis represents the budget and y-axis represents average probability of mortality. The green line represents
human-in-the-loop initialization and the purple line represents random initialization. Clearly, integrating a
“human into the loop” produces reduced mortality results, as compared to the random initialization result.
The results demonstrate the importance of the “human in the loop” component of our formulation. Never-
theless, the results also show that poor (i.e., random) initializations can still be turned into recommendations
that provide comparable benefits (in terms of probability improvement).
Similarly, Figure 6b shows relative probability improvement across varying budget levels using both
types of initialization. Again, the green line represents human-in-the-loop initialization and the purple line
represents random initialization. Here, we make the same observations that we do for Figure 6a. However,
we can also see that as the budget is increased, the results obtained from random initialization tends closer
to those obtained from physician initialization. This observation further shows that, provided a sufficiently
large budget, random initialization can come close to providing the same probabilistic improvement.
5.5 Human in the Loop Recommendations: Average Recommendations
In this section, we present the average recommendations made by our human in the loop method. While
many scoring criteria [44, 45, 46] and tools [40, 47] exist to assess the risk of mortality of septic patients,
there are limited studies that comprehensively assess risk, account for physician input, and provide treatment
recommendations. Our study and proposed method provides all three of these benefits. Therefore, in this
section we examine the recommendations produced by our method. It is impractical, however, to present
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Random
initialization
Human-in-loop
initialization
(a) Comparison of average probabilities of mortality con-
sidering inverse classifier with human-in-the-loop initial-
ization and with the random initialization.
Human-in-loop
initialization
Random
initialization
(b) Comparison of relative probability improvement in
mortality considering inverse classifier with human-in-the-
loop initialization and with the random initialization.
Figure 6: Human-in-the-loop vs. random initialization results.
individual recommendations and, as such, present average recommendations by budget value.
Figure 7 shows the average recommendation results obtained from applying our method. Each of the
Figures 7a to 7d represent a different budget level (0.3, 0.5, 0.7 and 0.9). The x-axis shows each IV fluid.
The y-axis represents the average recommended change to a physicians input. Therefore, deviation from a
value of zero represents a recommended change. A positive (negative) value indicates that the physicians
recommended IV fluid value should be increased (decreased). The results are further stratified by “predicted
positive”, shown in red, and “predicted negative” shown in blue. An instance was predicted as belonging
to the positive class, representing “expiration due to sepsis”, if their predicted probability of mortality was
greater than 50%, and negative otherwise.
Upon inspecting Figures 7a through 7d we can clearly see that an increased budget allows greater changes
to be made to a physicians suggested IV fluid values. For example, with budget of 0.3, the average suggested
change for D5LR for positive and negative predicted cases is 0.15 and 0.17, respectively. While the same for
budge of 0.9 is 0.47 and 0.51, respectively. These figures also provide the following insights:
1. On average, our model suggests increasing the intake of D5LR, D5HNS and D5W, while recommending
that LR and NS be decreased. These observations are in alignment with the literature [48] that suggests
that resuscitation using LR is associated with increased renal failure.
2. Resuscitation using 5% dextrose in lactate ringer is encouraged among septic patients in ICUs to
improve the probability of survival.
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(a) Budget = 0.3, estimated mortality = 0.44.
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(b) Budget = 0.5, estimated mortality = 0.43.
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(c) Budget = 0.7, estimated mortality = 0.40
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(d) Budget = 0.9, estimated mortality = 0.38.
Figure 7: Average recommendations at budget levels 0.3, 0.5, 0.7, and 0.9, stratified by predicted positive
test instances, shown in red, and predicted negative test instances, shown in blue.
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6 Conclusions
This study proposes a clinical prescriptive model with human in the loop functionality that recommends
optimal, individual-specific amounts of IV fluids for the treatment of septic patients in ICUs. The proposed
methodology combines constrained optimization and machine learning techniques to arrive at optimal so-
lutions. A key novelty of the proposed clinical model is utilization of a physician’s input to derive optimal
solutions. The efficacy of the method is demonstrated using a real world medical dataset. We further val-
idated the robustness of the proposed approach to show that our method benefits from the human in the
loop component, but is also robust to poor input, which is a crucial consideration for new physicians. The
results showed, under the limited budget, the optimal solution can improve the average relative probability of
survival by 22%. The proposed method can potentially be embedded in an existing electronic health record
system to make life-saving IV fluid recommendations. This model can also be used for training junior physi-
cians to synthesize the appropriate treatment strategy, and prevent user error after the inclusion of additional
clinical variables and prospective validation. An important limitation of the model is the non-inclusion of
vasopressors and antibiotics, which are two important classes of drugs used to treat sepsis.
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